VivoSim Labs, Inc. Prepaid Expense and Other Assets, Current
VivoSim Labs, Inc. (VIVS) had Prepaid Expense and Other Assets, Current of $511.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $511.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $557.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $709.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $882.00K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $511.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $557.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $709.00K 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $882.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $592.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $789.00K 10-K · filed 2026-07-14 | |
| 2024-12-31 | $913.00K 10-Q · filed 2025-02-19 | |
| 2024-09-30 | $940.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $640.00K 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $705.00K 10-K · filed 2025-06-05 | |
| 2023-12-31 | $913.00K 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $624.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $792.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $889.00K 10-K · filed 2024-05-31 | |
| 2022-12-31 | $788.00K 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $519.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $717.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $858.00K 10-K · filed 2023-07-14 | |
| 2021-12-31 | $902.00K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $512.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $650.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $1.03M 10-K · filed 2022-06-10 | |
| 2020-12-31 | $1.26M 10-Q · filed 2021-02-08 | |
| 2020-09-30 | $1.81M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $630.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $851.00K 10-K · filed 2021-06-15 | |
| 2019-12-31 | $474.00K 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $1.39M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $726.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.05M 10-K · filed 2020-05-28 | |
| 2018-12-31 | $527.00K 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $798.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $927.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.16M 10-K · filed 2019-06-03 | |
| 2017-12-31 | $891.00K 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $934.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.66M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.14M 10-K · filed 2018-05-31 | |
| 2016-12-31 | $589.00K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $908.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $1.03M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $968.00K 10-K · filed 2017-06-07 | |
| 2015-12-31 | $483.00K 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $714.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $795.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $1.05M 10-K · filed 2016-06-09 | |
| 2014-12-31 | $372.00K 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $616.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $712.00K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $931.00K 10-K · filed 2015-06-09 | $891.00K 10-K · filed 2014-06-10 |
| 2013-12-31 | $622.00K 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $304.00K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $327.00K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $327.00K 10-K · filed 2014-06-10 | |
| 2012-12-31 | $527.00K 10-K · filed 2014-06-10 | |
| 2012-09-30 | $144.51K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $204.49K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $144.80K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $80.00K 10-KT · filed 2013-05-24 | $79.87K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |